Frankfurt - Delayed Quote • EUR
AVITA Medical, Inc. (51KA.F)
At close: April 24 at 3:52 PM GMT+2
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. James M. Corbett | CEO, President & Executive Director | 1.08M | -- | 1958 |
| Mr. David O'Toole | Chief Financial Officer | 536.91k | -- | 1959 |
| Ms. Donna Shiroma | General Counsel, Chief Compliance Officer & Secretary | 643.39k | -- | 1963 |
| Mr. David Fencil | Senior Vice President of Global Operations | -- | -- | -- |
| Dr. Katie Bush Ph.D. | Senior Vice President of Scientific & Medical Affairs | -- | -- | -- |
| Ms. Jessica Ekeberg | Investor Relations Executive | -- | -- | -- |
| Ms. Debbie Garner | Senior Vice President of Global Marketing & Strategy | -- | -- | -- |
| Mr. Rob Hall | Senior Vice President of Human Resources | -- | -- | -- |
| Mr. Terry Bromley | Senior Vice President of Global Sales | -- | -- | -- |
| Dr. Niraj Doshi J.D., P.M.P., Ph.D. | Senior Vice President of Product Development & Program Management | -- | -- | -- |
AVITA Medical, Inc.
28159 Avenue Stanford
Suite 220
Valencia, CA 91355
United States
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 207
Description
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
Corporate Governance
AVITA Medical, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 6. The pillar scores are Audit: 8; Board: 2; Shareholder Rights: 5; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
May 13, 2024
AVITA Medical, Inc. Earnings Call